CO6341567A2 - Vacuna contra el virus de papiloma humano - Google Patents

Vacuna contra el virus de papiloma humano

Info

Publication number
CO6341567A2
CO6341567A2 CO11022213A CO11022213A CO6341567A2 CO 6341567 A2 CO6341567 A2 CO 6341567A2 CO 11022213 A CO11022213 A CO 11022213A CO 11022213 A CO11022213 A CO 11022213A CO 6341567 A2 CO6341567 A2 CO 6341567A2
Authority
CO
Colombia
Prior art keywords
vaccine against
papiloma virus
human papiloma
dose
vaccine
Prior art date
Application number
CO11022213A
Other languages
English (en)
Inventor
Dominique Descamps
Sandra Giannini
Martine Anne Cecile Wettendorff
Jean Stephenne
Nicolas Pierre Fernand Lecrenier
Original Assignee
Glaxosmithkline Biolog Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Biolog Sa filed Critical Glaxosmithkline Biolog Sa
Publication of CO6341567A2 publication Critical patent/CO6341567A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5258—Virus-like particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/20011—Papillomaviridae
    • C12N2710/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Abstract

El uso de partículas similares a virus (VLPs) de HPV 16 y HPV 18 junto con un excipiente farmacéuticamente aceptable, en una vacuna para la prevención de enfermedad o infección relacionada con virus de papiloma humano, en donde la vacuna se formula para administrarse de conformidad con un régimen de dos dosis que consiste de una primera dosis y una segunda dosis.
CO11022213A 2008-07-31 2011-02-23 Vacuna contra el virus de papiloma humano CO6341567A2 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US8510108P 2008-07-31 2008-07-31
US17656109P 2009-05-08 2009-05-08

Publications (1)

Publication Number Publication Date
CO6341567A2 true CO6341567A2 (es) 2011-11-21

Family

ID=41139260

Family Applications (1)

Application Number Title Priority Date Filing Date
CO11022213A CO6341567A2 (es) 2008-07-31 2011-02-23 Vacuna contra el virus de papiloma humano

Country Status (26)

Country Link
US (1) US20110189229A1 (es)
EP (1) EP2318042B1 (es)
JP (1) JP6022159B2 (es)
KR (1) KR20110053340A (es)
CN (1) CN102159239A (es)
AU (1) AU2009275909A1 (es)
BR (1) BRPI0916732B1 (es)
CA (1) CA2732436C (es)
CO (1) CO6341567A2 (es)
DK (1) DK2318042T3 (es)
DO (1) DOP2011000031A (es)
EA (1) EA201170264A1 (es)
ES (1) ES2519490T3 (es)
HR (1) HRP20141063T1 (es)
IL (1) IL210977A0 (es)
MA (1) MA32554B1 (es)
MX (1) MX2011001218A (es)
NZ (1) NZ590919A (es)
PE (1) PE20110327A1 (es)
PL (1) PL2318042T3 (es)
PT (1) PT2318042E (es)
RS (1) RS53607B1 (es)
SI (1) SI2318042T1 (es)
SM (1) SMT201400170B (es)
WO (1) WO2010012780A1 (es)
ZA (1) ZA201100889B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102497880A (zh) 2009-06-25 2012-06-13 葛兰素史密丝克莱恩生物有限公司 新的人乳头状瘤病毒(hpv)蛋白构建体及其在预防hpv疾病中的用途
CN102178944A (zh) * 2010-09-17 2011-09-14 大连雅立峰生物制药有限公司 人乳头瘤病毒16和18型l1蛋白在昆虫细胞中的表达及应用
CN102229660B (zh) 2011-05-25 2015-04-22 厦门大学 截短的人乳头瘤病毒33型l1蛋白
KR101559622B1 (ko) * 2012-07-30 2015-10-13 중앙대학교 산학협력단 인유두종바이러스 바이러스 유사입자의 고효율 정제방법
WO2016038625A2 (en) * 2014-09-11 2016-03-17 Cadila Healthcare Limited Superior human papilloma virus antigens with superior immunological properties and vaccine containing it
RU2628693C1 (ru) * 2016-11-10 2017-08-21 федеральное государственное бюджетное учреждение "Федеральный научно-исследовательский центр эпидемиологии и микробиологии имени почетного академика Н.Ф. Гамалеи" Министерства здравоохранения Российской Федерации (ФГБУ "ФНИЦЭМ им. Н.Ф. Гамалеи" Минздрава России) РЕКОМБИНАНТНЫЙ ГЕН L1HPV16, РЕКОМБИНАНТНАЯ ПЛАЗМИДА pQE-L1/16, БЕЛОК L1HPV16 И ИХ ПРИМЕНЕНИЕ

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9921146D0 (en) * 1999-09-07 1999-11-10 Smithkline Beecham Biolog Novel composition
US20070014810A1 (en) * 2003-12-31 2007-01-18 Denise Baker Inducing cellular immune responses to human papillomavirus using peptide and nucleic acid compositions
US7758866B2 (en) * 2004-06-16 2010-07-20 Glaxosmithkline Biologicals, S.A. Vaccine against HPV16 and HPV18 and at least another HPV type selected from HPV 31, 45 or 52
JP2008502633A (ja) * 2004-06-16 2008-01-31 グラクソスミスクライン バイオロジカルズ ソシエテ アノニム Ｈｐｖ１６およびｈｐｖ１８ならびにｈｐｖ３１、４５または５２から選ばれる少なくとも１つの別のｈｐｖ型に対するワクチン
EA013326B1 (ru) * 2005-04-26 2010-04-30 Глаксосмитклайн Байолоджикалс С.А. Вакцина

Also Published As

Publication number Publication date
KR20110053340A (ko) 2011-05-20
AU2009275909A1 (en) 2010-02-04
WO2010012780A1 (en) 2010-02-04
MA32554B1 (fr) 2011-08-01
JP6022159B2 (ja) 2016-11-09
BRPI0916732B1 (pt) 2021-06-29
US20110189229A1 (en) 2011-08-04
IL210977A0 (en) 2011-04-28
PE20110327A1 (es) 2011-06-29
EP2318042B1 (en) 2014-08-20
PT2318042E (pt) 2014-11-05
CN102159239A (zh) 2011-08-17
EA201170264A1 (ru) 2011-08-30
SMT201400170B (it) 2015-01-15
EP2318042A1 (en) 2011-05-11
CA2732436A1 (en) 2010-02-04
ZA201100889B (en) 2012-04-25
JP2011529475A (ja) 2011-12-08
MX2011001218A (es) 2011-03-15
CA2732436C (en) 2018-01-16
BRPI0916732A2 (pt) 2017-01-31
HRP20141063T1 (hr) 2015-01-02
DK2318042T3 (da) 2014-11-10
SI2318042T1 (sl) 2014-12-31
PL2318042T3 (pl) 2015-02-27
RS53607B1 (en) 2015-04-30
ES2519490T3 (es) 2014-11-07
NZ590919A (en) 2012-10-26
DOP2011000031A (es) 2011-02-28

Similar Documents

Publication Publication Date Title
CO6341567A2 (es) Vacuna contra el virus de papiloma humano
CY1122516T1 (el) Ετοιμες προς χρηση διατυπωσεις κετορολακης
MD4430B1 (ro) Compoziţii şi metode de tratament al hepatitei virale C
GEP20146134B (en) Inhibitors of hepatitis c virus replication
AR083361A1 (es) Forma de dosificacion de rapida disolucion de vacuna oral utilizando almidon
BR112012000287B8 (pt) composição farmacêutica para um inibidor de protease viral de hepatite c
CO6491048A2 (es) Inhibidores de la replicación de los virus de la gripe
JP2011246469A5 (es)
AR073265A1 (es) Uso de dronedarona para la preparacion de un medicamento para la prevencion de ictus o ataque isquemico transitorio
BR112018011331A2 (pt) mutante de proteìna l1 de papillomavirus humano tipo 11
IL182440A0 (en) Subtype-matched inactivated whole virus vaccines for treating patients with hiv infection
JP2006512413A5 (es)
CO2022011392A2 (es) Vacuna contra hpv
JP2011529475A5 (es)
AR054259A1 (es) Vacuna contra virus de papiloma humano (hpv)
WO2010045431A3 (en) Dry powder formulations, vaccines and methods
HRP20120930T1 (hr) Cjepivo protiv hpv16 i hpv18 i još najmanje jednog tipa hpv, kojeg se bira između hpv31, 45 ili 52
CA2650980A1 (en) Statins for the treatment of viral influenza infections
AR075866A1 (es) Una dosis de ave5026 para el tratamiento de tromboembolismo venoso en pacientes con deterioro renal severo. uso. composicion farmaceutica.
CY1115704T1 (el) Εμβολιο κατα του hpv
WO2020099696A1 (es) Uso de ésteres derivados del ácido gálico como antivirales
MD3121F1 (en) Method of viral hepatitis B prophylaxis
CN106336447A (zh) 南蛇藤素的应用
PE20151323A1 (es) Metadoxina para usarse en el tratamiento de enfermedades hepaticas y formulaciones de liberacion prolongada de metadoxina
HRP20151389T1 (hr) Antivirusni 2,5-dibenzimidazol-5-il-1-fenil-pirolidinderivat

Legal Events

Date Code Title Description
FC Application refused